Nathan Seppa has been the biomedical writer at Science News since 1997. Previously, he worked at the Wisconsin State Journal, a daily newspaper in Madison, where he inaugurated the science beat. In the 1980s, he covered energy and economics for the Dow Jones News Service in the Wall Street Journal's Washington Bureau. In the 1970s, Seppa served as a public health volunteer in the Peace Corps in Zaire, now Congo. He hails from the Upper Peninsula of Michigan, where he worked as a miner and gravedigger to pay his way through college. He has a B.S. in Sociology and a M.A. in Journalism. Nathan speaks French and knows enough Swahili to get out of a tight spot.
Nathan Seppa's Articles
- News in BriefHighlights from the pediatrics meeting held May 4-7 in Washington, D.C., include adolescent suicide risk and access to guns, a reason to let preemies get more umbilical cord blood and teens' cognitive dissonance on football concussions.
- NewsBut protection from some immune conditions fades after a decade, a study finds.
- News in BriefShots-plus-booster strategy deemed ineffective in preventing infection.
- NewsWater pipes deliver carcinogens, nicotine and carbon monoxide to the user, a study finds.
- NewsAltered mix of microbes might reduce susceptibility to viral infections.
- News in BriefNo tie found between colicky babies and later tension headaches.
- NewsCleansed of cells and repopulated anew, bioengineered organ successfully produces urine.
- News in BriefFermentation process using bioengineered version of the fungus could become important new production method for artemisinin.
- Deleted ScenesVitamin D seems to be living up to high expectations
Note: To comment, Science News subscribing members must now establish a separate login relationship with Disqus. Click the Disqus icon below, enter your e-mail and click “forgot password” to reset your password. You may also log into Disqus using Facebook, Twitter or Google.X
- NewsAn experimental medicine that uses a seek-and-destroy design to kill tumor cells may help some patients who face a recurrence.